Abstract��Fibrin glue or fibrin sealant has been used surgically as sealant for hemostasis for decades. At the same time, due to the biocompatibility of fibrin glue, it has been studied as a hydrogel drug delivery system, applied in clinical practice and biomedical engineering, especially suitable for local drug delivery for anti-tumor, antibiosis, wound healing, nerve regeneration, and bone healing after fracture. In recent years, novel functional vehicles such as liposomes, microspheres, and nanoparticles have been researched for the feasibility of combined use with fibrin glue. Drugs can be directly sent to the positions that need treatment by using fibrin glue as carriers. Additionally it can extend the residence time of drugs at the administration site and reduce administration frequency. The fibrin glue drug delivery system can also decrease blood drug concentration to avoid systemic adverse effects. This review will highlight recent research of fibrin glue as a drug delivery system.
�Ʋ�ʢ�����ı�����ǿ. ��ά��������ҩ����͵��о���չ[J]. �й�ҩѧ��־, 2017, 52(1): 8-13.
HUANG Chang-sheng, DAI Wen-bing, ZHANG Qiang. Advances in Drug Delivery Systems Using Fibrin Glue. Chinese Pharmaceutical Journal, 2017, 52(1): 8-13.
MATSUDA M,SUGO T,YOSHIDA N, et al. Structure and function of fibrinogen: Insights from dysfibrinogens. Thromb Haemost, 1999, 82(2):283-290.
[2]
WU X,REN J,YAO G, et al. Biocompatibility, biodegradation, and neovascularization of human single-unit platelet-rich fibrin glue: An in vivo analysis. Chin Med J (Engl), 2014, 127(3):408-411.
[3]
ANTONELLI M,CICCONETTI F,VIVINO G, et al. Closure of a tracheoesophageal fistula by bronchoscopic application of fibrin glue and decontamination of the oral cavity. Chest, 1991, 100(2):578-579.
[4]
RADOSEVICH M,GOUBRAN H I,BURNOUF T. Fibrin sealant: Scientific rationale, production methods, properties, and current clinical use. Vox Sang, 1997, 72(3):133-143.
[5]
FLAHIFF C,FELDMAN D,SALTZ R, et al. Mechanical properties of fibrin adhesives for blood vessel anastomosis. J Biomed Mater Res, 1992, 26(4):481-491.
[6]
SPICER P P,MIKOS A G. Fibrin glue as a drug delivery system. J Controlled Release, 2010, 148(1):49-55.
[7]
LEE H H,HALEEM A M,YAO V, et al. Release of bioactive adeno-associated virus from fibrin scaffolds: Effects of fibrin glue concentrations. Tissue Eng Part A, 2011, 17(15-16):1969-1978.
[8]
PARSI K,EXNER T,MA D D, et al. In vitro effects of detergent sclerosants on fibrinolytic enzymes and inhibitors. Thromb Res, 2010, 126(4):328-336.
[9]
BREEN A,O'BRIEN T,PANDIT A. Fibrin as a delivery system for therapeutic drugs and biomolecules. Tissue Eng Part B Rev, 2009, 15(2):201-214. YU B G,KWON I C,KIM Y H, et al. Development of a local antibiotic delivery system using fibrin glue. J Controlled Release, 1996, 39(1):65-70. ANAI S,HIDE T,TAKEZAKI T, et al. Antitumor effect of fibrin glue containing temozolomide against malignant glioma. Cancer Sci, 2014, 105(5):583-591. OPITZ I,ERNE B V,DEMIRBAS S, et al. Optimized intrapleural cisplatin chemotherapy with a fibrin carrier after extrapleural pneumonectomy: A preclinical study. J Thorac Cardiovasc Surg, 2011, 141(1):65-71. TOFUKU K,KOGA H,YANASE M, et al. The use of antibiotic-impregnated fibrin sealant for the prevention of surgical site infection associated with spinal instrumentation. Eur Spine J, 2012, 21(10):2027-2033. OZAKI S,SAITO A,NAKAMINAMI H, et al. Comprehensive evaluation of fibrin glue as a local drug-delivery system-efficacy and safety of sustained release of vancomycin by fibrin glue against local methicillin-resistant staphylococcus aureus infection. J Artif Organs, 2014, 17(1):42-49. ZHIBO X,MIAOBO Z. Effect of sustained-release lidocaine on reduction of pain after subpectoral breast augmentation. Aesthet Surg J, 2009, 29(1):32-34. FU J Z,LI J,YU Z L. Effect of implanting fibrin sealant with ropivacaine on pain after laparoscopic cholecystectomy. World J Gastroenterol, 2009, 15(46):5851-5854. KITAJIRI S,TABUCHI K,HIRAUMI H, et al. Relief of post-tonsillectomy pain by release of lidocaine from fibrin glue. Laryngoscope, 2001, 111(4 Pt 1):642-644. VIALE M,ROSSI M,RUSSO E, et al. Fibrin gels loaded with cisplatin and cisplatin-hyaluronate complexes tested in a subcutaneous human melanoma model. Invest New Drugs, 2015, 33(6):1151-1161. LIU L,CHIU P W,LAM P K, et al. Effect of local injection of mesenchymal stem cells on healing of sutured gastric perforation in an experimental model. Br J Surg, 2015, 102(2):e158-e168. WONG C,INMAN E,SPAETHE R, et al. Fibrin-based biomaterials to deliver human growth factors. Thromb Haemost, 2003, 89(3):573-582. GAO C,MA S,JI Y, et al. Siatic nerve regeneration in rats stimulated by fibrin glue containing nerve growth factor: An experimental study. Injury, 2008, 39(12):1414-1420. LIKHITPANICHKUL M,KIM Y,TORRE O M, et al. Fibrin-genipin annulus fibrosus sealant as a delivery system for anti-TNFalpha drug. Spine J, 2015, 15(9):2045-2054. MENDEZ J J,GHAEDI M,SIVARAPATNA A, et al. Mesenchymal stromal cells form vascular tubes when placed in fibrin sealant and accelerate wound healing in vivo. Biomaterials, 2015, 40:61-71. YOSHIDA H,YAMAOKA Y,SHINOYAMA M, et al. Novel drug delivery system using autologous fibrin glue--release properties of anti-cancer drugs. Biol Pharm Bull, 2000, 23(3):371-374. YOSHIDA H,YAMAOKA Y,SHINOYAMA M, et al. Novel drug delivery system using autologous fibrin glue--release properties of anti-cancer drugs. Biol Pharm Bull, 2000, 23(3):371-374. WOOD M D,BORSCHEL G H,SAKIYAMA-ELBERT S E. Controlled release of glial-derived neurotrophic factor from fibrin matrices containing an affinity-based delivery system. J Biomed Mater Res A, 2009, 89(4):909-918. ARRIGHI I,MARK S,ALVISI M, et al. Bone healing induced by local delivery of an engineered parathyroid hormone prodrug. Biomaterials, 2009, 30(9):1763-1771. SCHMOEKEL H G,WEBER F E,SCHENSE J C, et al. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol Bioeng, 2005, 89(3):253-262. TAJDARAN K,GORDON T,WOOD M D, et al. A glial cell line-derived neurotrophic factor delivery system enhances nerve regeneration across acellular nerve allografts. Acta Biomater, 2016, 29:62-70. TAJDARAN K,SHOICHET M S,GORDON T, et al. A novel polymeric drug delivery system for localized and sustained release of tacrolimus (FK506). Biotechnol Bioeng, 2015, 112(9):1948-1953. HAFELI U O,PAUER G J,UNNITHAN J, et al. Fibrin glue system for adjuvant brachytherapy of brain tumors with 188Re and 186Re-labeled microspheres. Eur J Pharm Biopharm, 2007, 65(3):282-288. ZHANG L,ZHANG L,LAN X, et al. Improvement in angiogenesis and osteogenesis with modified cannulated screws combined with VEGF/PLGA/fibrin glue in femoral neck fractures. J Mater Sci Mater Med, 2014, 25(4):1165-1172. WOOD M D,GORDON T,KEMP S W, et al. Functional motor recovery is improved due to local placement of GDNF microspheres after delayed nerve repair. Biotechnol Bioeng, 2013, 110(5):1272-1281. TANG P,YAO Q,ZHANG W, et al. A study of femoral neck fracture repair using a recombinant human bone morphogenetic protein-2 directional release system. Tissue Eng Part A, 2009, 15(12):3971-3978. ROYCE S M,ASKARI M,MARRA K G. Incorporation of polymer microspheres within fibrin scaffolds for the controlled delivery of FGF-1. J Biomater Sci Polym Ed, 2004, 15(10):1327-1336. HAN Y,ZENG Q,E L, et al. Sustained topical delivery of insulin from fibrin gel loaded with poly(lactic-co-glycolic acid) microspheres improves the biomechanical retention of titanium implants in type 1 diabetic rats. J Oral Maxillofac Surg, 2012, 70(10):2299-2308. WANG S S,YANG M C,CHUNG T W. Liposomes/chitosan scaffold/human fibrin gel composite systems for delivering hydrophilic drugs--release behaviors of tirofiban in vitro. Drug Deliv, 2008, 15(3):149-157. KARABEY-AKYUREK Y,GURCAY A G,GURCAN O, et al. Localized delivery of methylprednisolone sodium succinate with polymeric nanoparticles in experimental injured spinal cord model. Pharm Dev Technol, 2016:1-10. CHUNG Y I,AHN K M,JEON S H, et al. Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. J Controlled Release, 2007, 121(1-2):91-99. CHUNG Y I,KIM S K,LEE Y K, et al. Efficient revascularization by VEGF administration via heparin-functionalized nanoparticle-fibrin complex. J Controlled Release, 2010, 143(3):282-289. YU H,PENG J,GUO Q, et al. Improvement of peripheral nerve regeneration in acellular nerve grafts with local release of nerve growth factor. Microsurgery, 2009, 29(4):330-336. YAU L,MOLNAR P,MOON M C, et al. Meta-iodobenzylguanidine, an inhibitor of arginine-dependent mono(ADP-ribosyl)ation, prevents neointimal hyperplasia. J Pharmacol Exp Ther, 2008, 326(3):717-724. KANAZAWA R,SATO S,IWAMOTO N, et al. Allergic reaction following arachnoid plasty with a fibrin sealant. Neurol Med Chir (Tokyo), 2010, 50(7):608-610.
2017, Vol. 52 
